We have also uncovered a novel phenomenon where LKB1 is required for ovarian cancer cell survival and resistance to chemotherapy treatment in spheroids, whereas AMPK, the primary downstream substrate of LKB1, is dispensable. Here, PRKAA2 is linked to ovarian carcinoma.